Keywords: Johnson & Johnson, Russia investment, Skolkovo Foundation Venture fund, Research, Cancer, Tuberculosis, Hepatitis C

Johnson & Johnson invests $30 million in deal with Russia’s Skolkovo

Article | 23 June 2011

Print This

US health care giant Johnson & Johnson (NYSE: JNJ), together with its pharmaceutical division Janssen Pharmaceutica, has signed an agreement ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in